Moderna melanoma vaccine data misses lofty expectations, shares sink
Published 11 h ago2 sourcesEvidence: Reported
Moderna shares fell nearly 25% after a leaked study appeared on social media, per the Wall Street Journal. The leak's content and authenticity are unverified, creating uncertainty about the clinical or regulatory implications. The sharp move signals market sensitivity to unconfirmed data in the biotech sector.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Published 11 h ago2 sourcesEvidence: Reported
Published 19 h ago1 sourceEvidence: Unknown
Published 2 d ago1 sourceEvidence: Unknown
Published 2 d ago4 sourcesEvidence: Reported
Published 10 h ago1 sourceEvidence: Reported
Published 16 h ago4 sourcesEvidence: Reported
Published 17 h ago1 sourceEvidence: Reported
Published 1 d ago5 sourcesEvidence: Reported